{
  "main_header": {
    "sid": 131877,
    "name": "Indrapr.Medical",
    "stock_name": "Indrapr.Medical",
    "full_name": "Indraprastha Medical Corporation Ltd",
    "name_url": "stocks-analysis/indraprmedical",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "459.90",
    "chg": -6.75,
    "chgp": "-1.45%",
    "dir": -1,
    "prev_price": "466.65",
    "mcapval": "4,190.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532150,
    "symbol": "INDRAMEDCO",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE681B01017",
    "curr_date": "Dec 18",
    "curr_time": "",
    "bse_nse_vol": "1.37 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 18, 2025",
    "traded_date_str": "2025 12 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indraprmedical-131877-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Indrapr.Medical Sees Revision in Market Evaluation Amid Mixed Performance Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indraprmedical-downgraded-from-strong-buy-to-buy-by-marketsmojo-3755127",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IndraprMedical_mojoScore_3755127.png",
        "date": "2025-12-10 10:10:28",
        "description": "Indrapr.Medical's market evaluation has undergone a revision reflecting nuanced shifts across key analytical parameters. The recent assessment highlights a complex interplay of strong fundamentals tempered by valuation and technical considerations, set against a backdrop of fluctuating stock returns and sector dynamics."
      },
      {
        "title": "Why is Indrapr.Medical falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-indraprmedical-fallingrising-3747224",
        "imagepath": "",
        "date": "2025-12-05 00:51:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>Indraprastha Medical’s stock has been on a downward trajectory over the past week, registering a loss of 4.04%, significantly underperforming the Sensex, which declined by only 0.53% in the same period. The trend extends over the last month, where the stock plummeted by 18.62%, contrasting sharply with the Sensex’s 2.16% gain. Year-to-date, the stock remains down by 5.91%, while the benchmark index has advanced by 9.12%. Even over the last year, the stock has declined by 2.60%, whereas the Sensex has appreciated by 5.32%.</p>\n<p>Despite these short-term setbacks, the company’s longer-term performance remains exceptional. Over three years, Indraprastha Medical has delivered a staggering 476.79% return, vastly outpacing the Sensex’s ..."
      },
      {
        "title": "Is Indrapr.Medical overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-indraprmedical-overvalued-or-undervalued-3727273",
        "imagepath": "",
        "date": "2025-11-25 08:12:29",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Valuation Metrics Indicate Attractiveness</strong></p>\n<p>At a price-to-earnings (PE) ratio of approximately 26.8, Indrapr.Medical trades at a moderate valuation relative to its earnings. This figure is notably lower than many of its hospital sector peers, several of which command PE ratios well above 40 or even 70. The company’s price-to-book value stands at 7.12, reflecting a premium but not an excessive one given its strong return on equity (ROE) of 26.5% and return on capital employed (ROCE) exceeding 94%. These returns highlight efficient capital utilisation and profitability, justifying a valuation premium over book value.</p>\n<p>Enterprise value multiples further reinforce the stock’s appeal. The EV to EBITDA ratio of 16.5 is significantly more reasonable than competitors such as Max ..."
      },
      {
        "title": "Indraprastha Medical Corporation Valuation Shifts Highlight Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indraprastha-medical-corporations-valuation-turns-attractive-amid-market-volatility-3727246",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IndraprasthaMed_valuationdot_3727246.png",
        "date": "2025-11-25 08:00:08",
        "description": "Indraprastha Medical Corporation’s recent valuation parameters indicate a notable shift in price attractiveness within the hospital sector, as key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios reflect a more favourable market assessment compared to historical and peer averages."
      },
      {
        "title": "Indraprastha Medical Corporation Sees Shift in Technical Momentum Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indraprastha-medical-corporation-sees-technical-momentum-shift-amid-mixed-market-signals-3723601",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IndraprasthaMed_technicaldot_3723601.png",
        "date": "2025-11-24 08:00:16",
        "description": "Indraprastha Medical Corporation, a key player in the hospital sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent market data reveals a mild adjustment in the company’s evaluation metrics, with technical indicators presenting a mixed picture that warrants close attention from investors and market analysts alike."
      },
      {
        "title": "Is Indrapr.Medical technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-indraprmedical-technically-bullish-or-bearish-3716876",
        "imagepath": "",
        "date": "2025-11-20 08:10:55",
        "description": "As of 19 November 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both weekly and monthly time frames, while the daily moving averages also indicate a bullish trend. Although the Bollinger Bands show a mildly bullish signal on both weekly and monthly charts, the KST is bullish weekly but mildly bearish monthly, and Dow Theory indicates a mildly bearish weekly stance against a bullish monthly view. Overall, the strength of the bullish trend is reinforced by the recent price movement, with the current price at 534.80, up from the previous close of 520.00...."
      },
      {
        "title": "Indraprastha Medical Corporation Shows Bullish Momentum Amid Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indraprastha-medical-corporation-technical-momentum-shifts-signal-bullish-outlook-3717070",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IndraprasthaMed_technicaldot_3717070.png",
        "date": "2025-11-20 08:00:22",
        "description": "Indraprastha Medical Corporation, a key player in the hospital sector, has exhibited a notable shift in its technical momentum, reflecting evolving market dynamics. Recent evaluation adjustments highlight a transition towards a more bullish technical trend, supported by multiple indicators across daily, weekly, and monthly timeframes. This article analyses the current technical landscape, price movements, and comparative returns to provide a comprehensive view of the stock’s market position."
      },
      {
        "title": "Is Indrapr.Medical technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-indraprmedical-technically-bullish-or-bearish-3713837",
        "imagepath": "",
        "date": "2025-11-19 08:14:18",
        "description": "As of 18 November 2025, the technical trend has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by the weekly and monthly MACD readings, which are both bullish. The Bollinger Bands also indicate a mildly bullish trend on both weekly and monthly time frames. However, the KST shows a mixed signal with weekly bullishness and monthly mild bearishness, while Dow Theory indicates a mildly bearish stance on the weekly but bullish on the monthly. The daily moving averages reflect a mildly bullish outlook. Overall, the indicators suggest a cautious bullish sentiment, tempered by some mixed signals in the longer time frames...."
      },
      {
        "title": "Is Indrapr.Medical overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-indraprmedical-overvalued-or-undervalued-3713559",
        "imagepath": "",
        "date": "2025-11-19 08:08:12",
        "description": "As of 18 November 2025, the valuation grade for Indrapr.Medical has moved from attractive to fair, indicating a shift in its perceived value. The company is currently fairly valued. Key ratios include a PE ratio of 27.31, an EV to EBITDA of 16.83, and a PEG ratio of 1.50. \n\nIn comparison to its peers, Indrapr.Medical's valuation appears moderate, especially when compared to Max Healthcare, which is very expensive with a PE of 77.03, and Apollo Hospitals, which is attractive with a PE of 63.51. Notably, Indrapr.Medical has outperformed the Sensex over the past year with a return of 26.65% compared to the Sensex's 9.48%, reflecting its strong performance despite the recent grade change...."
      }
    ],
    "total": 379,
    "sid": "131877",
    "stock_news_url": "https://www.marketsmojo.com/news/indraprastha-medical-corporation-131877"
  },
  "announcements": [
    {
      "details": "Indraprastha Medical Corporation Limited has informed the Exchange regarding issue of duplicate share certificates.",
      "source": "NSE",
      "caption": "Indraprastha Medical Corporation Limited - Other General Purpose",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Indraprastha Medical Corporation Limited has informed the Exchange regarding Board meeting held on November 05, 2019.",
      "source": "NSE",
      "caption": "Indraprastha Medical Corporation Limited - Outcome of Board Meeting",
      "datetime": "05-Nov-2019"
    },
    {
      "details": "Indraprastha Medical Corporation Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015",
      "source": "NSE",
      "caption": "Indraprastha Medical Corporation Limited - Trading Window",
      "datetime": "26-Sep-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indraprastha Medical Corporation Ltd has declared <strong>45%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Indrapr.Medical Sees Revision in Market Evaluation Amid Mixed Performance Metrics

2025-12-10 10:10:28

Indrapr.Medical's market evaluation has undergone a revision reflecting nuanced shifts across key analytical parameters. The recent assessment highlights a complex interplay of strong fundamentals tempered by valuation and technical considerations, set against a backdrop of fluctuating stock returns and sector dynamics.

Read More

Why is Indrapr.Medical falling/rising?

2025-12-05 00:51:36

Recent Price Movement and Market Performance

Indraprastha Medical’s stock has been on a downward trajectory over the past week, registering a loss of 4.04%, significantly underperforming the Sensex, which declined by only 0.53% in the same period. The trend extends over the last month, where the stock plummeted by 18.62%, contrasting sharply with the Sensex’s 2.16% gain. Year-to-date, the stock remains down by 5.91%, while the benchmark index has advanced by 9.12%. Even over the last year, the stock has declined by 2.60%, whereas the Sensex has appreciated by 5.32%.

Despite these short-term setbacks, the company’s longer-term performance remains exceptional. Over three years, Indraprastha Medical has delivered a staggering 476.79% return, vastly outpacing the Sensex’s ...

Read More

Is Indrapr.Medical overvalued or undervalued?

2025-11-25 08:12:29

Valuation Metrics Indicate Attractiveness

At a price-to-earnings (PE) ratio of approximately 26.8, Indrapr.Medical trades at a moderate valuation relative to its earnings. This figure is notably lower than many of its hospital sector peers, several of which command PE ratios well above 40 or even 70. The company’s price-to-book value stands at 7.12, reflecting a premium but not an excessive one given its strong return on equity (ROE) of 26.5% and return on capital employed (ROCE) exceeding 94%. These returns highlight efficient capital utilisation and profitability, justifying a valuation premium over book value.

Enterprise value multiples further reinforce the stock’s appeal. The EV to EBITDA ratio of 16.5 is significantly more reasonable than competitors such as Max ...

Read More

Indraprastha Medical Corporation Valuation Shifts Highlight Price Attractiveness

2025-11-25 08:00:08

Indraprastha Medical Corporation’s recent valuation parameters indicate a notable shift in price attractiveness within the hospital sector, as key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios reflect a more favourable market assessment compared to historical and peer averages.

Read More

Indraprastha Medical Corporation Sees Shift in Technical Momentum Amid Mixed Market Signals

2025-11-24 08:00:16

Indraprastha Medical Corporation, a key player in the hospital sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent market data reveals a mild adjustment in the company’s evaluation metrics, with technical indicators presenting a mixed picture that warrants close attention from investors and market analysts alike.

Read More

Is Indrapr.Medical technically bullish or bearish?

2025-11-20 08:10:55

As of 19 November 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both weekly and monthly time frames, while the daily moving averages also indicate a bullish trend. Although the Bollinger Bands show a mildly bullish signal on both weekly and monthly charts, the KST is bullish weekly but mildly bearish monthly, and Dow Theory indicates a mildly bearish weekly stance against a bullish monthly view. Overall, the strength of the bullish trend is reinforced by the recent price movement, with the current price at 534.80, up from the previous close of 520.00....

Read More

Indraprastha Medical Corporation Shows Bullish Momentum Amid Technical Shifts

2025-11-20 08:00:22

Indraprastha Medical Corporation, a key player in the hospital sector, has exhibited a notable shift in its technical momentum, reflecting evolving market dynamics. Recent evaluation adjustments highlight a transition towards a more bullish technical trend, supported by multiple indicators across daily, weekly, and monthly timeframes. This article analyses the current technical landscape, price movements, and comparative returns to provide a comprehensive view of the stock’s market position.

Read More

Is Indrapr.Medical technically bullish or bearish?

2025-11-19 08:14:18

As of 18 November 2025, the technical trend has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by the weekly and monthly MACD readings, which are both bullish. The Bollinger Bands also indicate a mildly bullish trend on both weekly and monthly time frames. However, the KST shows a mixed signal with weekly bullishness and monthly mild bearishness, while Dow Theory indicates a mildly bearish stance on the weekly but bullish on the monthly. The daily moving averages reflect a mildly bullish outlook. Overall, the indicators suggest a cautious bullish sentiment, tempered by some mixed signals in the longer time frames....

Read More

Is Indrapr.Medical overvalued or undervalued?

2025-11-19 08:08:12

As of 18 November 2025, the valuation grade for Indrapr.Medical has moved from attractive to fair, indicating a shift in its perceived value. The company is currently fairly valued. Key ratios include a PE ratio of 27.31, an EV to EBITDA of 16.83, and a PEG ratio of 1.50. In comparison to its peers, Indrapr.Medical's valuation appears moderate, especially when compared to Max Healthcare, which is very expensive with a PE of 77.03, and Apollo Hospitals, which is attractive with a PE of 63.51. Notably, Indrapr.Medical has outperformed the Sensex over the past year with a return of 26.65% compared to the Sensex's 9.48%, reflecting its strong performance despite the recent grade change....

Read More

View All News